| Literature DB >> 31995748 |
Jeremy A Sullivan1, Yusuke Tomita2, Ewa Jankowska-Gan2, Diego A Lema2, Matt P Arvedson2, Ashita Nair3, William Bracamonte-Baran2, Ying Zhou2, Kristy K Meyer4, Weixiong Zhong4, Deepali V Sawant5, Andrea L Szymczak-Workman5, Qianxia Zhang5, Creg J Workman5, Seungpyo Hong6, Dario A A Vignali7, William J Burlingham2.
Abstract
Interleukin-35 (IL-35) is an immunosuppressive cytokine composed of Epstein-Barr-virus-induced protein 3 (Ebi3) and IL-12α chain (p35) subunits, yet the forms that IL-35 assume and its role in peripheral tolerance remain elusive. We induce CBA-specific, IL-35-producing T regulatory (Treg) cells in TregEbi3WT C57BL/6 reporter mice and identify IL-35 producers by expression of Ebi3TdTom gene reporter plus Ebi3 and p35 proteins. Curiously, both subunits of IL-35 are displayed on the surface of tolerogen-specific Foxp3+ and Foxp3neg (iTr35) T cells. Furthermore, IL-35 producers, although rare, secrete Ebi3 and p35 on extracellular vesicles (EVs) targeting a 25- to 100-fold higher number of T and B lymphocytes, causing them to acquire surface IL-35. This surface IL-35 is absent when EV production is inhibited or if Ebi3 is genetically deleted in Treg cells. The unique ability of EVs to coat bystander lymphocytes with IL-35, promoting exhaustion in, and secondary suppression by, non-Treg cells identifies a novel mechanism of infectious tolerance.Entities:
Keywords: CD81; Ebi3; IL-35; Treg; cytokines; extracellular vesicles; p35; tetraspanin; tolerance; exosome
Mesh:
Substances:
Year: 2020 PMID: 31995748 PMCID: PMC7042971 DOI: 10.1016/j.celrep.2019.12.081
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423